- Home
- NOTV vs RAND Comparison
NOTV vs RAND Comparison
Compare NOTV & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTV
- RAND
- Stock Information
- Founded
- NOTV 1974
- RAND 1969
- Country
- NOTV United States
- RAND United States
- Employees
- NOTV N/A
- RAND N/A
- Industry
- NOTV Biotechnology: Pharmaceutical Preparations
- RAND Finance: Consumer Services
- Sector
- NOTV Health Care
- RAND Finance
- Exchange
- NOTV Nasdaq
- RAND Nasdaq
- Market Cap
- NOTV 62.5M
- RAND 57.6M
- IPO Year
- NOTV 1997
- RAND N/A
- Fundamental
- Price
- NOTV $1.85
- RAND $18.32
- Analyst Decision
- NOTV Strong Buy
- RAND
- Analyst Count
- NOTV 1
- RAND 0
- Target Price
- NOTV $5.00
- RAND N/A
- AVG Volume (30 Days)
- NOTV 488.3K
- RAND 5.0K
- Earning Date
- NOTV 08-07-2025
- RAND 08-05-2025
- Dividend Yield
- NOTV N/A
- RAND 9.10%
- EPS Growth
- NOTV N/A
- RAND 39.77
- EPS
- NOTV N/A
- RAND 3.12
- Revenue
- NOTV $480,402,000.00
- RAND $8,499,970.00
- Revenue This Year
- NOTV $4.99
- RAND N/A
- Revenue Next Year
- NOTV $5.39
- RAND N/A
- P/E Ratio
- NOTV N/A
- RAND $5.61
- Revenue Growth
- NOTV N/A
- RAND 12.52
- 52 Week Low
- NOTV $1.15
- RAND $14.95
- 52 Week High
- NOTV $6.48
- RAND $31.89
- Technical
- Relative Strength Index (RSI)
- NOTV 40.47
- RAND 76.65
- Support Level
- NOTV $2.06
- RAND $16.26
- Resistance Level
- NOTV $2.30
- RAND $16.89
- Average True Range (ATR)
- NOTV 0.15
- RAND 0.68
- MACD
- NOTV 0.00
- RAND 0.30
- Stochastic Oscillator
- NOTV 29.69
- RAND 69.46
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.